Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Dawn of a European Health Data Space – Challenges

Posted on July 16th, 2020 by in Pharma R&D

The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. In a previous post, we briefly described the essence of the envisioned heath data space and pointed at opportunities and possible starting points to transform this vision into reality.

(more…)

What were the most important lessons in Life Sciences in 2019?

Posted on December 20th, 2019 by in Pharma R&D

As 2019 comes to a close, we asked members of Elsevier’s Life Sciences team:

What were the biggest lessons or most noteworthy developments in the Life Sciences industry this year?

(more…)

Machine Learning Could Make Drug Discovery Faster, Cheaper, Better

Posted on November 6th, 2018 by in Pharma R&D

The stats on the increasingly high cost (and low success rates) in drug discovery are always jarring. As Phee Waterfield of Binary District Journal reports:

  • Bringing a new drug to market is estimated to cost major pharma firms more than $4 billion
  • The process can take 10-15 years
  • Fewer than 10% actually make it to market

(more…)

Big Talks on Big Data are Coming to Bio IT World

Posted on May 9th, 2018 by in Pharma R&D

At next week’s Bio IT World conference and expo (Boston, May 15-17), Elsevier will be giving four talks on the implications of AI and machine learning on life science research, a statistical analysis of concordance between animal toxicities and human adverse events, strategies for increasing data sharing and the latest technologies being used to integrate multiple data sources. (more…)

  1. 1
  2. 2
  3. 3
  4. 6